Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11705 |
JAK-IN-4
|
Others | Others |
JAK-IN-4 is a prodrug of a JAK inhibitor, effective in murine collagen induced arthritis model. | |||
T11708 |
JAK2-IN-4
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK2-IN-4 is a selective JAK2/JAK3 inhibitor, with IC50 values of 0.7 nM and 23.2 nM for JAK2 and JAK3, respectively. | |||
T15606 |
JAK1-IN-4
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK1-IN-4 is a selective JAK1 inhibitor (IC50s: 85 nM, 12.8 μM and >30 μM for JAK1, JAK2, and JAK3, respectively). JAK1-IN-4 inhibits STAT3 phosphorylation in NCI-H 1975 cells (IC50, 227 nM). | |||
T4657L |
WHI-P97 HCl 211555-05-4(free base)
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
WHI-P97 HCl 211555-05-4(free base) 是一种有效的选择性 JAK-3 抑制剂。 WHI-P97 在模型研究中估计 Ki 值为 0.09 microM,在 EGFR 激酶抑制试验中测得的 IC50 值为 2.5 microM。 WHI-P97以浓度依赖性方式有效抑制EGFR 阳性人癌细胞的体外侵袭性。 | |||
T73330 |
JAK-IN-24
|
||
JAK-IN-24 是一种 JAK 抑制剂,在 4 μM 或 1 mM ATP 存在时,IC50分别为 0.534 和 24 nM。JAK-IN-24 还抑制 PBMCIL-15诱导的 STAT5磷酸化,IC50为 86.171 nM。 | |||
T69766 |
Gusacitinib HCl
|
||
Gusacitinib, also known as ASN-002 and EN-3351, is a potent dual inhibitor of SYK/JAK kinases. ASN002 showed strong antitumor activity in both hematological and solid tumor xenograft models. ASN002 strongly suppressed the SYK and JAK family kinase signaling pathways as measured in pLAT and pSTAT assays, respectively. When profiled in a panel of 178 cell lines, ASN002 showed strong anti-proliferative activity in many lymphoid/leukemia cell lines, including SU-DHL-6, SU-DHL-4, OCI-LY10, H929 and... | |||
T78708 |
JAK/HDAC-IN-2
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK/HDAC-IN-2 是一款高效的 JAK/HDAC 双靶点抑制剂,能在纳摩尔浓度范围内有效抑制 HDAC3/6 与 JAK1/2。此化合物不仅促进细胞凋亡,还能抑制组蛋白去乙酰化和 STAT3 磷酸化,对血液肿瘤和实体肿瘤细胞展现出了显著的抗增殖效果。 |